Table 1.
Clinical and immunological data of patients included in the study.
| Group | Time of ART initiation | Number HIV-1 DNA copies | CD4 + T cell number | CD8 + T cell number | CD4 + /CD8 + ratio | Months on ART |
|---|---|---|---|---|---|---|
| LR | LA | < 10 | 890 | 1187 | 0.75 | 27 |
| LR | EA | 80 | 1340 | 957 | 1.40 | 14 |
| LR | EA | 86 | 600 | 556 | 1.08 | 21 |
| LR | EA | 89 | 580 | 382 | 1.52 | 36 |
| LR | EA | 126 | 1090 | 795 | 1.37 | 36 |
| LR | EA | 216 | 930 | 603 | 1.54 | 33 |
| LR | EA | 544 | 1280 | 955 | 1.34 | 16 |
| LR | EA | 548 | 1100 | 696 | 1.58 | 33 |
| LR | LA | 574 | 690 | 812 | 0.85 | 46 |
| LR | EA | 631 | 1110 | 941 | 1.18 | 25 |
| HR | LA | 716 | 840 | 1217 | 0.69 | 17 |
| HR | LA | 956 | 720 | 878 | 0.82 | 13 |
| HR | EA | 1341 | 760 | 559 | 1.36 | 7 |
| HR | LA | 1681 | 810 | 1173 | 0.69 | 36 |
| HR | LA | 2289 | 780 | 1083 | 0.72 | 25 |
| HR | LA | 2852 | 610 | 824 | 0.74 | 37 |
| HR | LA | 3135 | 960 | 980 | 0.98 | 15 |
| HR | EA | 3669 | 450 | 395 | 1.14 | 17 |
| HR | LA | 5102 | 980 | 1065 | 0.92 | 33 |
| HR | LA | 20.029 | 1000 | 990 | 1.01 | 45 |
LR low reservoir, HR high reservoir, EA early ART, LA late ART.